Deka Bank Deutsche Girozentrale Theravance Biopharma, Inc. Transaction History

Deka Bank Deutsche Girozentrale

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$8.33 - $12.96 $491,736 - $765,054	-59,032 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$7.42 - $11.05 $57,742 - $85,991	7,782 Added 15.18%	59,032 $623,000
Q2 2021 Aug 05, 2021	SELL	$14.52 - $22.46 $217,800 - $336,900	-15,000 Reduced 22.64%	51,250 $760,000
Q4 2020 Mar 12, 2021	BUY	$14.89 - $20.16 $472,013 - $639,072	31,700 Added 91.75%	66,250 $1.17 Million
Q3 2020 Oct 29, 2020	BUY	$14.79 - $22.49 $379,156 - $576,553	25,636 Added 287.59%	34,550 $515,000
Q1 2020 May 14, 2020	BUY	$17.84 - $31.21 $159,025 - $278,205	8,914 New	8,914 $203,000
Q4 2019 Feb 04, 2020	SELL	$16.12 - $25.89 $154,752 - $248,544	-9,600 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.51 - $23.78 $158,496 - $228,288	-9,600 Reduced 50.0%	9,600 $187,000
Q2 2019 Aug 01, 2019	BUY	$15.6 - $25.15 $117,000 - $188,625	7,500 Added 64.1%	19,200 $306,000
Q1 2019 May 10, 2019	BUY	$22.57 - $28.15 $47,397 - $59,115	2,100 Added 21.88%	11,700 $337,000
Q4 2018 Feb 12, 2019	SELL	$22.52 - $35.07 $47,292 - $73,647	-2,100 Reduced 17.95%	9,600 $223,000
Q3 2018 Nov 09, 2018	SELL	$22.83 - $32.67 $6,848 - $9,801	-300 Reduced 2.5%	11,700 $0
Q2 2018 Aug 14, 2018	SELL	$22.06 - $25.52 $264,720 - $306,240	-12,000 Reduced 50.0%	12,000 $275,000
Q1 2018 May 03, 2018	SELL	$23.37 - $29.71 $11,685 - $14,855	-500 Reduced 2.04%	24,000 $563,000
Q3 2017 Nov 06, 2017	BUY	$23.88 - $34.96 $585,060 - $856,520	24,500	24,500 $662,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.